| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.069 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |